Primary |
Mental Disorder |
16.0% |
Pain |
12.0% |
Preoperative Care |
12.0% |
Obsessive-compulsive Disorder |
8.0% |
Product Used For Unknown Indication |
8.0% |
Restlessness |
8.0% |
Sedation |
8.0% |
Dislocated Elbow |
4.0% |
Endotracheal Intubation |
4.0% |
Forearm Fracture |
4.0% |
Joint Dislocation |
4.0% |
Sedative Therapy |
4.0% |
Septic Shock |
4.0% |
Stupor |
4.0% |
|
Biliary Dilatation |
5.3% |
Drug Abuse |
5.3% |
Hypoxia |
5.3% |
Incorrect Dose Administered |
5.3% |
Laryngospasm |
5.3% |
Medication Error |
5.3% |
Myoclonus |
5.3% |
Procedural Complication |
5.3% |
Pyelonephritis Acute |
5.3% |
Pyramidal Tract Syndrome |
5.3% |
Salivary Hypersecretion |
5.3% |
Sleep Disorder |
5.3% |
Suicidal Ideation |
5.3% |
Tonic Clonic Movements |
5.3% |
Toxicity To Various Agents |
5.3% |
Vasodilatation |
5.3% |
Visual Impairment |
5.3% |
Weight Increased |
5.3% |
Wrong Technique In Drug Usage Process |
5.3% |
|
Secondary |
Product Used For Unknown Indication |
16.0% |
Sedation |
12.3% |
Cancer Pain |
10.1% |
Supplementation Therapy |
7.4% |
Drug Use For Unknown Indication |
6.5% |
Anaesthesia |
5.5% |
Hypertension |
5.5% |
Vitamin Supplementation |
5.1% |
Pancreatitis |
4.3% |
Antibiotic Level |
3.0% |
Diuretic Therapy |
2.9% |
Pain |
2.9% |
Antibiotic Therapy |
2.8% |
Muscle Relaxant Therapy |
2.8% |
Anaesthesia Procedure |
2.5% |
Polyuria |
2.5% |
Induction Of Anaesthesia |
2.0% |
Mineral Supplementation |
2.0% |
Vascular Operation |
2.0% |
Thermal Burn |
1.7% |
|
Toxic Epidermal Necrolysis |
38.9% |
Shock |
6.9% |
Somnolence |
5.6% |
Venoocclusive Disease |
5.6% |
Partial Seizures |
4.2% |
Polyneuropathy In Malignant Disease |
4.2% |
Anaphylactic Reaction |
2.8% |
Anaphylactic Shock |
2.8% |
Cardiac Arrest |
2.8% |
Foetal Growth Restriction |
2.8% |
Hepatocellular Injury |
2.8% |
Respiratory Depression |
2.8% |
Stevens-johnson Syndrome |
2.8% |
Supraventricular Tachycardia |
2.8% |
Tachycardia |
2.8% |
Transient Ischaemic Attack |
2.8% |
Trismus |
2.8% |
Abdominal Discomfort |
1.4% |
Amnesia |
1.4% |
Anaphylactoid Shock |
1.4% |
|
Concomitant |
Sedation |
8.5% |
Product Used For Unknown Indication |
8.1% |
Anaesthesia |
7.7% |
Drug Use For Unknown Indication |
7.7% |
Anaesthesia Procedure |
6.8% |
Pancreatitis |
6.8% |
Induction Of Anaesthesia |
6.4% |
Analgesic Therapy |
5.6% |
Crohn's Disease |
4.7% |
Perioperative Analgesia |
4.3% |
Back Pain |
3.8% |
Cancer Pain |
3.8% |
Electrolyte Substitution Therapy |
3.8% |
Pain In Extremity |
3.8% |
Maintenance Of Anaesthesia |
3.4% |
Prophylaxis Against Gastrointestinal Ulcer |
3.4% |
Acute Lymphocytic Leukaemia |
3.0% |
Pain |
3.0% |
Alcohol Withdrawal Syndrome |
2.6% |
Hypertension |
2.6% |
|
Injection Site Thrombosis |
11.1% |
Withdrawal Syndrome |
11.1% |
Inadequate Analgesia |
8.3% |
Pain In Extremity |
5.6% |
Polyuria |
5.6% |
Post Procedural Haemorrhage |
5.6% |
Pyrexia |
5.6% |
Sinus Tachycardia |
5.6% |
Stevens-johnson Syndrome |
5.6% |
Trismus |
5.6% |
Vomiting |
5.6% |
Bradycardia |
2.8% |
Bronchopulmonary Aspergillosis |
2.8% |
Cardiac Arrest |
2.8% |
Cardio-respiratory Arrest |
2.8% |
Crohn's Disease |
2.8% |
Drug Exposure During Pregnancy |
2.8% |
Drug Ineffective |
2.8% |
Drug Interaction |
2.8% |
Gamma-glutamyltransferase Increased |
2.8% |
|